Abella, Evangeline B.

HRN: 29-02-58  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2026
CEFTRIAXONE 1G (VIAL)
05/20/2026
05/26/2026
IV
2gm
OD
Urosepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: